The global adenosylmethionine (SAMe) market is expected to reach USD 5.2 billion by 2030, growing at a CAGR of 4.6% from 2021 to 2030. The growth in this market can be attributed to the rise in the incidence of depression and osteoarthritis, which are two major conditions being treated with SAMe therapy. Rising prevalence of liver disorders and fibromyalgia also contributes to the growth in this market.
On the basis of type, the liquid SAMe segment is projected have higher revenue (USD 1 billion) than the tablet segment (USD 0.7 billion). Rising popularity among consumers for liquid formulations can be attributed as one factor contributing to this development; however, sales would depend on regulatory approvals from regulatory bodies like US FDA or European Medicines Agency (EMA). The rise in incidence rate due to depression and osteoarthritis drives demand for SAMe tablets globally; hence, it will have higher revenue than liquid formulations through 2030.
The US SAMe market is expected to reach USD 2.7 billion by 2030, growing at a CAGR of 3.5% from 2021 to 2030. The market is projected to be the largest in North America and second-largest globally, following Europe.
The high growth in this region can be attributed to the large population base and rising incidence of depression, which has been considered as a major cause for psycho-somatic illness in the US. Further, it will help maintain the demand for SAMe therapy products through 2030 because there will be no effective substitute drug available; coupled with strong support from healthcare providers in this region due to lack of alternatives that are equally effective and have less side effects for treating major conditions like osteoarthritis and depression.
On the basis of therapeutic application, depression would generate more revenue than osteoarthritis through 2030 (USD 1 billion vs USD 0.7 billion). Depression contributes significantly higher revenue than osteoarthritis due to its high prevalence rate among adults as well as adolescents globally (4% vs 4%). According to WHO data, nearly one out of five adults exhibits depressive symptoms at any given point in time; hence it would continue generating higher revenue over foreseeable future owing further rise in incidence rates due to change in life style patterns such as increased use social media platforms leading poor mental health status among consumers worldwide.
On the basis of therapeutic area, the depression segment is forecasted to have higher revenue than osteoarthritis. As SAMe is primarily used as an antidepressant, it follows that it will have higher revenue through 2030. The therapy for liver disorders and fibromyalgia are expected to be lower in terms of revenue through 2030.
North America will account for the highest market share as SAMe has been commercially available there since 1950s and 1980s respectively. However, in Asia Pacific region, SAMe was only approved in 2009; hence it will not show significant growth till 2020-2025 even though its use has been documented for over 40 years ago due to traditional practices and herbal remedies in this region.
Industry Growth Insights published a new data on “S-Adenosylmethionine (SAMe) Market”. The research report is titled “S-Adenosylmethionine (SAMe) Market research by Types (SAMe Tablets, Liquid SAMe), By Applications (Depression, Osteoarthritis, Supplementation, Liver Disorders, Fibromyalgia, Other), By Players/Companies KAL - Nutraceutical, Gnosis S.p.A., Changsha Natureway, Beijing Oriental Rada Biotech Co., Amrita Nutrition”.
Scope Of The Report
Report Attributes
Report Details
Report Title
S-Adenosylmethionine (SAMe) Market Research Report
By Type
SAMe Tablets, Liquid SAMe
By Application
Depression, Osteoarthritis, Supplementation, Liver Disorders, Fibromyalgia, Other
By Companies
KAL - Nutraceutical, Gnosis S.p.A., Changsha Natureway, Beijing Oriental Rada Biotech Co., Amrita Nutrition
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global S-Adenosylmethionine (SAMe) Market Report Segments:
The global S-Adenosylmethionine (SAMe) market is segmented on the basis of:
Types
SAMe Tablets, Liquid SAMe
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Depression, Osteoarthritis, Supplementation, Liver Disorders, Fibromyalgia, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- KAL - Nutraceutical
- Gnosis S.p.A.
- Changsha Natureway
- Beijing Oriental Rada Biotech Co.
- Amrita Nutrition
 Market Overview.svg)
Highlights of The S-Adenosylmethionine (SAMe) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SAMe Tablets
- Liquid SAMe
- By Application:
- Depression
- Osteoarthritis
- Supplementation
- Liver Disorders
- Fibromyalgia
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the S-Adenosylmethionine (SAMe) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
S-Adenosylmethionine (SAMe) is a molecule that plays an important role in the body's metabolism. It is converted into methyl groups, which are then used to make proteins and other molecules. SAMe can also help to protect cells from damage by free radicals.
Some of the major players in the s-adenosylmethionine (same) market are KAL - Nutraceutical_x000D_, Gnosis S.p.A._x000D_, Changsha Natureway_x000D_, Beijing Oriental Rada Biotech Co._x000D_, Amrita Nutrition.
The s-adenosylmethionine (same) market is expected to register a CAGR of 4.6%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. S-Adenosylmethionine (SAMe) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. S-Adenosylmethionine (SAMe) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. S-Adenosylmethionine (SAMe) Market - Supply Chain
4.5. Global S-Adenosylmethionine (SAMe) Market Forecast
4.5.1. S-Adenosylmethionine (SAMe) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. S-Adenosylmethionine (SAMe) Market Size (000 Units) and Y-o-Y Growth
4.5.3. S-Adenosylmethionine (SAMe) Market Absolute $ Opportunity
5. Global S-Adenosylmethionine (SAMe) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Type
5.3.1. SAMe Tablets
5.3.2. Liquid SAMe
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global S-Adenosylmethionine (SAMe) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Application
6.3.1. Depression
6.3.2. Osteoarthritis
6.3.3. Supplementation
6.3.4. Liver Disorders
6.3.5. Fibromyalgia
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global S-Adenosylmethionine (SAMe) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global S-Adenosylmethionine (SAMe) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global S-Adenosylmethionine (SAMe) Demand Share Forecast, 2019-2026
9. North America S-Adenosylmethionine (SAMe) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Application
9.4.1. Depression
9.4.2. Osteoarthritis
9.4.3. Supplementation
9.4.4. Liver Disorders
9.4.5. Fibromyalgia
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Type
9.7.1. SAMe Tablets
9.7.2. Liquid SAMe
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America S-Adenosylmethionine (SAMe) Demand Share Forecast, 2019-2026
10. Latin America S-Adenosylmethionine (SAMe) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Application
10.4.1. Depression
10.4.2. Osteoarthritis
10.4.3. Supplementation
10.4.4. Liver Disorders
10.4.5. Fibromyalgia
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Type
10.7.1. SAMe Tablets
10.7.2. Liquid SAMe
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America S-Adenosylmethionine (SAMe) Demand Share Forecast, 2019-2026
11. Europe S-Adenosylmethionine (SAMe) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Application
11.4.1. Depression
11.4.2. Osteoarthritis
11.4.3. Supplementation
11.4.4. Liver Disorders
11.4.5. Fibromyalgia
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Type
11.7.1. SAMe Tablets
11.72. Liquid SAMe
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe S-Adenosylmethionine (SAMe) Demand Share, 2019-2026
12. Asia Pacific S-Adenosylmethionine (SAMe) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Application
12.4.1. Depression
12.4.2. Osteoarthritis
12.4.3. Supplementation
12.4.4. Liver Disorders
12.4.5. Fibromyalgia
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Type
12.7.1. SAMe Tablets
12.7.2. Liquid SAMe
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific S-Adenosylmethionine (SAMe) Demand Share, 2019-2026
13. Middle East & Africa S-Adenosylmethionine (SAMe) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Application
13.4.1. Depression
13.4.2. Osteoarthritis
13.4.3. Supplementation
13.4.4. Liver Disorders
13.4.5. Fibromyalgia
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa S-Adenosylmethionine (SAMe) Market Size and Volume Forecast by Type
13.7.1. SAMe Tablets
13.7.2. Liquid SAMe
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa S-Adenosylmethionine (SAMe) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global S-Adenosylmethionine (SAMe) Market: Market Share Analysis
14.2. S-Adenosylmethionine (SAMe) Distributors and Customers
14.3. S-Adenosylmethionine (SAMe) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. KAL - Nutraceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Gnosis S.p.A.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Changsha Natureway
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beijing Oriental Rada Biotech Co.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Amrita Nutrition
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
